Can the human body be tricked into defending itself from viral infections? We interviewed Dr. Rajan George, Adjunct Faculty of the University of Albertas Pharmacy and Pharmaceutical Sciences Department. Dr. George is also Vice President of Research and Development for the Division of Infection Diseases of ViRexx Medical Co. As part of the team of University of Alberta scientists, a therapeutic vaccine is now being developed which may inoculate against Hepatitis, Anthrax and Avian Flu H5N1.
Could Virexx Medicals ‘Linked Recognition’ Research Lead To A Cancer Vaccine?
A SCIENTIST’S 20-YEAR UNFINISHED JOURNEY TO TREAT HBV MAY OPEN THE DOOR TO A NEW CLASS OF FLEXIBLE VACCINES
While preparing a lecture in biochemistry and virology for his graduate students at the University of Alberta in the early 1980s, Dr. Lorne Tyrrell ran across a study just published in the medical journal, Cell. The research by William Mason and Jesse Summers, entitled Replication of Hepatitis B, discussed their study of the hepatitis B virus in infected duck liver…
What Should I Know About Hepatitis B?
Hepatitis B remains one of those scary terms that you occasionally hear health care professionals use. You also hear about this somewhat mysterious disease in the media from time to time. But just what is Hepatitis B and what should we know about it?
Could ViRexx Medicals Linked Recognition Research Lead to a Cancer Vaccine?
Dr. Lorne Tyrrell pioneered lamivudine as the standard treatment for hepatitis B virus (HBV). Now a success, he observed the drugs shortcomings. Now CEO of ViRexx Medical, Tyrrell hopes his latest development, Chimigen, will offer new hope for HBV, other infectious diseases, and cancer.